|
|
 |
|
Viewing report
|
|
 |
 |
Contraceptive Devices: How is the Performance of Contraceptive Device Manufacturers Perceived by Ob/Gyn surgeons?
Valid Results, April 2008
This report provides an in-depth measurement and the relative importance of the following criteria in evaluating the performance of contraceptive device manufacturers: Product quality, Pricing, Innovation, Training/Continuing education, Sales reps, Surgeon support/ Customer service, Clinical data, Business assistance (marketing, advertising), Breadth of product line and Product value. The report also provides strategies to contraceptive device manufacturers to boost customer loyalty by providing recommendations for sales and marketing on which product and organizational characteristics to emphasize.
The following manufacturers are included in this study: Barr Pharmaceuticals, Berlex Labs, Conceptus, Cooper Surgical, Gyrus ACMI, Organon and Wyeth.
Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
The number of respondents to this survey is 40. We also have more studies available with increased survey respondents. Please use our Contact Us page for further details on pricing.
Customers who bought this item also bought
Contraceptive Devices: How is the Performance of Contraceptive Device Manufacturers Perceived by Ob/Gyn surgeons?
World Contraceptive and Infertility Drug Markets
Contraceptive Devices: Gap Analysis � Opportunities and Threats in the Contraceptive Device Market
Contraceptive Devices: Improving Birth Control Device Manufacturers Sales Rep Performance
The 2007-2012 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in India
The 2007-2012 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in Japan
The Global Market For Hormonal Contraceptives and Infertility Drugs, 2005-2012
The 2007-2012 World Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals
|
 |
|
|